Search Results for “research” – Page 269 – media

Lilly’s Verzenio bags third breast cancer nod

Eli Lilly’s Verzenio has been given another green light in the US for breast cancer, significantly expanding the drug’s treatment scope.
- Source: Pharmatimes
- 608
- March 1, 2018
breast cancer New Approvals
Viela Bio Spins Out of MedImmune; Raises Up to $250 Million in Series A Financing, 6 Dimensions Capital Leads Investment

Viela Bio announced today that it has incorporated as an independent, inflammation - and autoimmunity - focused biotechnology company after spinning out from MedImmune, the global biologics research and development arm of AstraZeneca. Viela Bio will primarily focus on developing medicines for severe autoimmune diseases by targeting critical pathways that are the root cause of the diseases.
- Source: finance.yahoo
- 475
- March 1, 2018
autoimmunity inflammation Market Views
Implanted continuous glucose sensor proven safe

Senseonics Holdings Inc has announced that people with diabetes using the Eversense® brand Continuous Glucose Monitoring Systems, in EMEA markets now have the option to invite others to remotely view their real-time glucose readings and alerts from anywhere.
- Source: globalbiotechinsights
- 714
- February 28, 2018
diabetes medical device mHealth New Approvals
Johnson & Johnson Medical Devices Companies Acquire Orthotaxy to Develop Next-Generation Robotic-Assisted Surgery Platform in Orthopaedics

Orthotaxy’s Technology Will Be Leveraged to Develop Cost-Effective, Time-Efficient, User-Friendly Offering in a Broad Range of Orthopaedics Procedures.
- Source: Jnj
- 522
- February 27, 2018
Market Views Orthopaedics
Cedars-Sinai, Emulate partner to give precision medicine a boost with organs-on-chips tech

The technology could enable researchers to test drugs or treatments on a patient’s cells to avoid harmful, ineffective and costly options while determining personalized regimens.
- Source: Healthcare IT News
- 548
- February 27, 2018
digital health medtech precision medicine Researches
AI Biotech XtalPi Closes Series B Round Funding from Sequoia China, Google, and Tencent

XtalPi Inc., a computation-driven pharmaceutical technology company, announced that it has closed a Series B funding round of 15 million USD led by Sequoia China, with participation from Google and existing investor Tencent. To date, XtalPi has raised over 20 million USD, making it one of the top-funded AI-powered biotechs.
- Source: finance.yahoo
- 523
- February 26, 2018
biotechs Market Views Series
Merck Drops $394 Million to Acquire Virus-Based Cancer Company Viralytics

Merck & Company is driving forward in its quest to develop a premier immuno-oncology pipeline. The company plunked down $394 million to acquire Australia-based Viralytics Ltd and its oncolytic immunotherapy treatments.
- Source: Biospace;
- 726
- February 26, 2018
immuno-oncology pipelin immunotherapy Market Views Merk
U.S. Food and Drug Administration Approves Gilead’s Biktarvy® (Bictegravir, Emtricitabine, Tenofovir Alafenamide) for Treatment of HIV-1 Infection

Gilead Sciences, Inc.(NASDAQ:GILD) today announced that the U.S. Food and Drug Administration (FDA) has approved Biktarvy® (bictegravir 50mg/emtricitabine 200mg/tenofovir alafenamide 25mg, BIC/FTC/TAF), a once-daily single tablet regimen (STR) for the treatment of HIV-1 infection. Biktarvy combines the novel, unboosted integrase strand transfer inhibitor (INSTI) bictegravir, with the demonstrated safety and efficacy profile of the Descovy® (FTC/TAF) dual nucleoside reverse transcriptase inhibitor (NRTI) backbone, and is the smallest INSTI-based triple-therapy STR available.
- Source: gilead
- 906
- February 26, 2018
Biktarvy FDA Gilead Sciences HIV-1 infection
Choices for Your Ideal Medical Hospital Beds

Nursing facilities and home- and community-based services are important for individuals' well-being and can often prevent the need for acute inpatient hospitalizations, which is why it’s important to choose suitable medical hospital beds. Ddu, the leading global pharmaceutical & medical device B2B online platform, now offers you some suggestions on how to choose your medical hospital beds.
- Source: Ddu
- 976
- February 26, 2018
Ddu College hospital beds
What’s Driving the Global Surgical Robotics Market

According to a new market research report by BIS Research, the global surgical robotics market is expected to reach a value of $12.6 billion by the year 2025.
- Source: marketresearch.com
- 1,224
- February 26, 2018
healthcare technologies and innovations Market Reports Market Views surgical

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.